Gemcitabine

Symptoms / Indications

• Non-small cell lung cancer
• Pancreatic cancer
• Breast cancer
• Ovarian cancer
• Bladder cancer
• Metastatic cancer conditions
• Tumor progression and malignancies

Product Overview

Gemcitabine for Injection 1 gm is a chemotherapeutic agent belonging to the class of antimetabolites, widely used in oncology for the treatment of various solid tumors. It plays a significant role in modern cancer therapy due to its ability to inhibit cancer cell growth and proliferation. Gemcitabine is often used as a single agent or in combination with other chemotherapy drugs for enhanced therapeutic outcomes.

Manufactured under stringent quality standards, this injectable formulation ensures sterility, stability, and consistent efficacy. It is suitable for hospitals, oncology centers, and pharmaceutical distributors seeking reliable oncology products. With export-grade packaging and regulatory compliance, Gemcitabine Injection is ideal for global markets requiring high-quality anticancer medications.

Therapeutic Category

Antineoplastic Agent (Antimetabolite)

Dosage Form

Injection

Mechanism of Action

Gemcitabine is a nucleoside analog that interferes with DNA synthesis. It gets incorporated into the DNA of rapidly dividing cells, leading to inhibition of DNA replication and ultimately causing cell death. By targeting proliferating cancer cells, it helps slow tumor growth and progression. Its cytotoxic effect makes it effective in various malignancies.

Dosage & Administration

Gemcitabine Injection should be administered by a qualified healthcare professional in a clinical setting. The dosage and treatment schedule depend on the type and severity of cancer and patient condition. It is typically given intravenously. Proper medical supervision is essential to monitor response and minimize adverse effects.

Side Effects

• Nausea and vomiting
• Fatigue
• Low blood cell counts
• Fever or flu-like symptoms

Precautions & Warnings

Use only under strict medical supervision in specialized oncology settings. Regular monitoring of blood counts, liver, and kidney function is required. Dose adjustments may be necessary in patients with organ impairment. Avoid self-medication and ensure proper clinical evaluation before use.

Drug Interactions

Gemcitabine may interact with other chemotherapeutic agents, immunosuppressants, and radiation therapy, potentially increasing toxicity. Concomitant use should be carefully monitored by healthcare professionals to avoid adverse effects.

Pregnancy & Breastfeeding

Pregnancy: Consult doctor before use
Breastfeeding: Consult doctor before use

Storage

Store in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.

Shelf Life

24 months

Quality & Compliance

This product is manufactured in a WHO-GMP compliant facility following strict quality assurance protocols. Each batch is tested for sterility, potency, and stability to meet international standards. It is suitable for export markets with complete regulatory and documentation support.

Business Opportunity

Allotab Healthcare is a leading pharmaceutical manufacturer and exporter operating from a WHO-GMP and EU-GMP certified facility in India, ensuring the highest standards of quality and compliance. We offer a wide range of pharmaceutical formulations including tablets, capsules, injections, ointments, oral liquids, and advanced molecules, catering to diverse therapeutic segments. Our portfolio also includes a comprehensive range of oncology products, supporting global healthcare needs. With strong manufacturing capabilities, regulatory expertise, and reliable supply, Allotab Healthcare serves distributors, hospitals, and healthcare organizations across international markets.

We offer reliable bulk supply of Gemcitabine Injection for oncology centers, hospitals, and global distributors. Custom packaging, competitive pricing, and export support are available to meet international market requirements.

Disclaimer

This information is for informational purposes only. Use under medical supervision.